These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20689383)

  • 41. [Epidemiological study on contact examinations done by Nishio Health Center using QFT from 2008 to 2010].
    Inoue T
    Kekkaku; 2011 Jul; 86(7):709-15. PubMed ID: 21922780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Tuberculosis in Poland in 2010].
    Korzeniewska-Koseła M
    Przegl Epidemiol; 2012; 66(2):329-34. PubMed ID: 23101226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrating the client's perspective in planning a tuberculosis education and treatment program in Honduras.
    Mata JI
    Med Anthropol; 1985; 9(1):57-64. PubMed ID: 4079701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tuberculosis in health care workers during declining tuberculosis incidence in New York State.
    Driver CR; Stricof RL; Granville K; Munsiff SS; Savranskaya G; Kearns C; Christie A; Oxtoby M
    Am J Infect Control; 2005 Nov; 33(9):519-26. PubMed ID: 16260327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of Cobas Amplicor MTB test to detect Mycobacterium tuberculosis in pulmonary and extrapulmonary specimens.
    Ozkutuk A; Kirdar S; Ozden S; Esen N
    New Microbiol; 2006 Oct; 29(4):269-73. PubMed ID: 17201093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tuberculosis--a notifiable disease.
    Roy S; Rai DR; Suresh G
    J Indian Med Assoc; 2012 Oct; 110(10):728-31. PubMed ID: 23738407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Completeness and timeliness of notifiable disease reporting: a comparison of laboratory and provider reports submitted to a large county health department.
    Dixon BE; Zhang Z; Lai PTS; Kirbiyik U; Williams J; Hills R; Revere D; Gibson PJ; Grannis SJ
    BMC Med Inform Decis Mak; 2017 Jun; 17(1):87. PubMed ID: 28645285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Benefits and barriers to electronic laboratory results reporting for notifiable diseases: the New York City Department of Health and Mental Hygiene experience.
    Nguyen TQ; Thorpe L; Makki HA; Mostashari F
    Am J Public Health; 2007 Apr; 97 Suppl 1(Suppl 1):S142-5. PubMed ID: 17413058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice.
    Uplekar M; Atre S; Wells WA; Weil D; Lopez R; Migliori GB; Raviglione M
    Eur Respir J; 2016 Dec; 48(6):1571-1581. PubMed ID: 27824601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Completeness and timeliness of tuberculosis case reporting. A multistate study.
    Curtis AB; McCray E; McKenna M; Onorato IM
    Am J Prev Med; 2001 Feb; 20(2):108-12. PubMed ID: 11165451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Timeliness of Measles Laboratory Reporting and Factors Associated with Delays, Zhejiang Province, China, 2009-2015.
    He H; Yan R; Fan C; Jing F; Ding Y
    Health Secur; 2017; 15(5):494-499. PubMed ID: 28937792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of message type on physician compliance with disease reporting requirements.
    Brissette I; Gelberg KH; Grey AJ
    Public Health Rep; 2006; 121(6):703-9. PubMed ID: 17278405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Systematic assessment on the improvement of tuberculosis case detection through general hospital-based tuberculosis patients transferring system in China].
    Wang XM; Liu JJ; Yao HY; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):661-5. PubMed ID: 15555386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Timeliness of notification systems for infectious diseases: A systematic literature review.
    Swaan C; van den Broek A; Kretzschmar M; Richardus JH
    PLoS One; 2018; 13(6):e0198845. PubMed ID: 29902216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Public-private mix in tuberculosis.
    Ukwaja KN
    Lancet Infect Dis; 2012 Dec; 12(12):908. PubMed ID: 23174377
    [No Abstract]   [Full Text] [Related]  

  • 56. Public-private mix in tuberculosis.
    Mishra GP
    Lancet Infect Dis; 2012 Dec; 12(12):908-9. PubMed ID: 23174376
    [No Abstract]   [Full Text] [Related]  

  • 57. Public-private mix in tuberculosis.
    Saurabh S; Sarkar S; Premarajan K; Sujiv A
    Lancet Infect Dis; 2012 Dec; 12(12):907-8. PubMed ID: 23174375
    [No Abstract]   [Full Text] [Related]  

  • 58. Public-private mix in tuberculosis - Authors' reply.
    Creswell J; Yasin Z; Sahu S; Khan AJ
    Lancet Infect Dis; 2012 Dec; 12(12):909-10; author reply 910-1. PubMed ID: 23174378
    [No Abstract]   [Full Text] [Related]  

  • 59. Tuberculosis control: business models for the private sector.
    Baloch NA; Pai M
    Lancet Infect Dis; 2012 Aug; 12(8):579-80. PubMed ID: 22704777
    [No Abstract]   [Full Text] [Related]  

  • 60. Ontario court justice dismisses class action suit of persons notified of exposure to tuberculosis.
    Stoltz L
    HIV AIDS Policy Law Rev; 2010 Jun; 14(3):33-4. PubMed ID: 21188946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.